About Healthcare Service Provider
29 Jul 2026Healthcare Service Provider is one of 6 industries in the Healthcare sector. Solomo tracks 37 listed companies classified as Healthcare Service Provider on India's NSE and BSE, out of 335 in the Healthcare sector. Their combined market capitalisation was ₹78,978 crore on 29 Jul 2026, 2.3% of the Healthcaresector's total and the 3rd largest of its 6 industries by market value. All 37 carry both an NSE symbol and a BSE scrip code.
The 3 largest by market capitalisation are Dr Lal Pathlabs Ltd (₹28,379 crore), Vijaya Diagnostic Centre Ltd (₹14,297 crore) and Metropolis Healthcare Ltd (₹11,752 crore).
Median trailing P/E across the 32 companies with a reported ratio is 27.7, and median return on capital employed (ROCE) across 37 companies is 8.4%.
| Company | Market cap | P/E | ROCE |
|---|---|---|---|
| Dr Lal Pathlabs Ltd | ₹28,379 Cr | 56.2 | 25.6% |
| Vijaya Diagnostic Centre Ltd | ₹14,297 Cr | 82.7 | 19.3% |
| Metropolis Healthcare Ltd | ₹11,752 Cr | 61.8 | 16.3% |
| Thyrocare Technologies Ltd | ₹8,209 Cr | 50.4 | 33.9% |
| Nephrocare Health Services Ltd | ₹6,495 Cr | 84.5 | 13.2% |
| Krsnaa Diagnostics Ltd | ₹1,807 Cr | 17.8 | 10.4% |
| One Global Service Provider Ltd | ₹1,807 Cr | 17.8 | 10.4% |
| Suraksha Diagnostic Ltd | ₹1,376 Cr | 42.8 | 14.4% |
| Health X Platform Ltd | ₹1,032 Cr | 535.0 | -0.1% |
| 3B Blackbio DX Ltd | ₹990 Cr | 16.9 | 23.6% |
| Gaudium IVF and Women Health Ltd | ₹907 Cr | 37.1 | 20.2% |
| Chandan Healthcare Ltd | ₹610 Cr | 20.9 | 19.6% |
| Vaidya Sane Ayurved Laboratories Ltd | ₹193 Cr | 21.5 | 12.7% |
| Star Imaging and Path Lab Ltd | ₹163 Cr | 8.5 | 20.6% |
| Vijaypd Ceutical Ltd | ₹138 Cr | 27.5 | 9.1% |
| Nephro Care India Ltd | ₹118 Cr | 35.0 | 8.4% |
| Aspira Pathlab & Diagnostics Ltd | ₹103 Cr | 42.9 | 13.2% |
| Invicta Diagnostic Ltd | ₹87 Cr | 17.7 | 13.4% |
| Choksi Laboratories Ltd | ₹85 Cr | 56.4 | 8.8% |
| Modern Diagnostic & Research Centre Ltd | ₹79 Cr | 15.0 | 8.8% |
Other industries in Healthcare: Pharmaceuticals (218), Hospital (37), Biotechnology (6), Healthcare Research, Analytics & Technology (11) and Medical Equipment & Supplies (26).
Market capitalisation, P/E and ROCE are from Solomo's fundamentals snapshot dated 29 Jul 2026; the interactive table above re-prices market cap and P/E against live quotes during market hours, so intraday figures there will differ. Sector and industry labels follow the NSE and BSE classification, and any market-cap rank quoted above is taken across Solomo's full NSE and BSE universe. Reference data, not investment advice.